GeoVax to Participate in Upcoming November Investor and Industry Events
ATLANTA, GA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November.
- ATLANTA, GA, Oct. 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that members of its senior management team and other scientific representatives will participate in four upcoming investor and industry events during November.
- Event details are as follows:
For more information and to register to attend the GeoVax Presentation, please visit Emerging Growth Conference . - Senior GeoVax management will host one-on-one meetings with registered attendees.
- If interested in meeting with management at this event, please contact the company through the conference portal, or directly at [email protected].